Genetic polymorphisms of biotranformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas

International Archives of Occupational and Environmental Health

Volumn 75, Issue SUPPL., 2002, Pages

  Soucek, P ^a   Sarmanova J ^a   Kristensen, V N ^b   Apltauerova M ^c   Gut, I ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cytochromes P450; Epoxide hydrolase; Genotypes; Glutathione S transferases; Lymphomas

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 2E1; ENZYME; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

AGE; ASSAY; BIOTRANSFORMATION; CANCER GRADING; CANCER GROWTH; CANCER SIZE; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA FLANKING REGION; EXON; FEMALE; GENDER; GENE DELETION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HODGKIN DISEASE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; METABOLISM; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; ARTICLE; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY;

CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2E1; EPOXIDE HYDROLASES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEX FACTORS;

EID: 0036820542     PISSN: 03400131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (46)

1. Bastrad C, Deweindt C, Kerckaert JP, Lenormand B, Rossi A, Pezzella F, et al. (1994) LAZ3 rearrangements in non-Hodgkin's lymphoma: Correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood 83:2423-2427
2. Benhamou S, Reinikainen M, Bouchardy C, Dayer P, Hirvonen A (1998) Association between lung cancer and microsomal exposide hydrolase genotypes. Cancer Res 58:5291-5293
3. Board PG (1989) Isolation of a cDNA clone and localization of the human glutathione S-transferase 3 genes to chromosome band 11q13 and 12q13-14. Ann Hum Genet 53:205-213
4. D'Errico A, Taioli E, Chen X, Vineis P (1996) Genetic metabolic polymorphisms and the risk of cancer, a review of the literature. Biomarkers 1:149
5. El-Zein RA, Zwischenberger JB, Wood T, Abdel-Rahman SZ, Brekelbaum C, Au WW (1997) Combined genetic polymorphism and risk for development of lung cancer. Mutat Res 381:189-200
6. Garte S, Crosti F (1999) A nomenclature system for metabolic gene polymorphisms. IARC Sci Publ 148:5-12
7. Guengerich FP (1995) Human cytochrome P450 enzymes. In: Ortiz de Montellano PR (ed) Cytochrome P450. Plenum Press, New York, pp 473-535
8. Harth V, Donat S, Ko Y, Abel J, Vetter H, Bruning T (2000) NAD(P)H quinone oxidoreductase 1 codon 609 polymorphism and its association to colorectal cancer. Arch Toxicol 73:528-531
9. Hassett C, Aicher L, Sidhu JS, Omiecinski CJ (1994) Human microsomal epoxide hydrolase: Genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3:421-428
10. Hayashi S, Watanabe J, Nakachi K, Kawajiri K (1991) Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem 110:407-411
11. Hayes JD, Pulford DL (1995) The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30:445-600
12. Helzsouer KJ, Selmin O, Huang HY, Strickland PT, Hoffman S, Albert AJ et al. (1998) Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and the development of breast cancer. J Natl Cancer Inst 90:512-518
13. Hildesheim A, Chen CJ, Caporaso NE, Cheng Y-J, Hoover RN, Hsu M-M, Levine PH, Chen I-H, Chen J-Y, Yang C-S, Daly AK, Idle JR (1995) Cytochrome P4502E1 genetic polymorphism and risk of nasopharyngeal carcinoma: Results from a case-control study conducted in Taiwan. Cancer Epidemiol Biomarkers Prev 4:607-610
14. IARC (1999) Metabolic Polymorphisms and Susceptibility to Cancer. Scientific Publication No. 148, Lyon, France
15. Iida S, Rao PH, Nallasivam P, Hibshoosh H, Butler M, Louie DC, et al. (1996) The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood 84:1361-1392
16. Ingelman-Sundberg M, Oscarson M, Daly AK, Garte S, Nebert DW (2001) Human cytochrome P-450 (CYP) genes: A web page for the nomenclature of alleles. Cancer Epidemiol Biomarkers Prev 10:1307-1308
17. Inoue K, Yamazaki H, Shimada T (2000) Characterization of liver microsomal 7-ethoxycoumarin O-deethylation and chlorzoxazone 6-hydroxylation activities in Japanese and Caucasian subjects genotyped for CYP2E1 gene. Arch Toxicol 74:372-378
18. Jourenkova-Mironova N, Mitrunen K, Bouchardy C, Dayer P, Benhamou S, Hirvonen A (2000) High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers. Cancer Res 60:534-536
19. Kihara M, Kihara M, Noda K (1995) Risk of smoking for squamous and small cell carcinomas of the lung and modulated by combinations of CYP1A1 and GSTM1 gene polymorphism in a Japanese population. Carcinogenesis 16:2331-2336
20. Kolcová V, Geryk E, Jechová M (1999) Zhoubné novotvary CR a vybrané státy (in Czech) NOR, Brno
21. Krajinovic M, Labuda D, Richer C, Karimi S, Sinnett D (1999) Susceptibility to childhood acute lymphoblastic leukemia: Influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood 93:1496-1501
22. Lancaster JM, Brownlee HA, Bell DA, Futreal PA, Marks JR, Berchuck A, et al. (1996) Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol Carcinog 17:160-162
23. Larson RA, Wang Y, Banerjee M, et al. (1999) Prevalence of the inactivating 609C - > T polymorphism in the NAD(P)H: Quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood 94:803-807
24. Lemos MC, Cabrita FJ, Silva HA, Vivan M, Plácido F, Regateiro FJ (1999) Genetic polymorphims of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias. Carcinogenesis 20:1225-1229
25. Louguemaux S, Delomenie C, Gallou C, Mejean A, Vincent-Viry M, Bouvier R et al. (1999) Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: A study of polymorphic human xenobiotic-metabolizing enzymes. Cancer Res 59:2903-2908
26. Merup M (1998) Genetic abnormalities in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Med Oncol 15:79-88
27. Morris SW, Naeve C, Matthew P, James PL, Kirstein MN, Cui X, Witte DP (1997) ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene 14:2175-2188
28. Nakachi K, Hayashi S, Kawajiri K, Imai K (1995) Association of cigarette smoking and CYP1A1 polymorphism with adenocarcinoma of the lung by grades of differentiation. Carcinogenesis 16:2209-2213
29. Nedelcheva-Kristensen V, Andersen TI, Erikstein B, Geitvik G, Skovlund E, Nesland JM, Børresen-Dale A-L (1998) Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: Relation of genotypes of TP53 tumor status and clinicopathological variables in breast cancer patients. Pharmacogenetics 8:441-447
30. Oyama T, Kawamoto T, Mizoue T, Sugio K, Kodama Y, Mitsudomi T, Yasumoto K (1997) Cytochrome P450 2E1 polymorphism as a risk factor for lung cancer in relation to p53 gene mutation. Anticancer Res 17:583-587
31. Park JY, Schantz SP, Stern JC, Kaur T, Lazarus P (1999) Association between glutathione S-transferase pi genetic polymorphisms and oral cancer risk. Pharmacogenetics 9:497-504
32. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB (1994) Human glutathione S-transferase Theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300:271-276
33. Raunio H, Husgafvel-Pursiainen K, Anttila S, Hietanen E, Hirvonen A, Pelkonen O (1995) Diagnosis of polymorphism in carcinogen-activating and inactivating enzymes and cancer susceptibility - A review. Gene 159:113-121
34. Rebbeck TR (1997) Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 6:733-743
35. Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, Øgreid D, Ulvik A, Vu P, Haugen A (1997) Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 18:1285-1289
36. Šrmanová J, Týnková L, Šůsová S, Gut I, Soucek P (2000) Genetic polymorphisms of biotransformation enzymes: Allele frequencies in the population of the Czech Republic. Pharmacogenetics 10:781-788
37. Schulz WA, Krummeck A, Roesinger I, et al. (1997) Increased frequency of a null-allele of NAD(P)H: Quinone oxidoreductase in patients with urological malignancies. Pharmacogenetics 7:235-239
38. Sivaraman L, Leathman MP, Yee J, Wilkens LR, Lau AF, Marchand LL (1994) CYP1A1 genetic polymorphism and in situ colorectal cancer. Cancer Res 54:3692-3695
39. Smith CAD, Harrison DJ (1997) Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350:630-633
40. Taioli E, Trachman J, Chen X, Toniolo P, Garte SJ (1995) A CYP1A1 restriction fragment length polymorphism is associated with cancer in African-American woman. Cancer Res 55:3757-3758
41. Traver RD, Siegel D, Beall HD, et al. (1997) Characterization of a polymorphism in NAD(P)H: Quinone oxidoreductase (DT-diaphorase). Br J Cancer 75:69-75
42. Uematsu F, Kikuchi H, Motomiya M, Abe T, Sagami I, Ohmachi A, Kanamaru R, Watanabe M (1991) Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer. Jpn J Cancer Res 82:254-256
43. Wu X, Shi H, Jiang H, Kemp H, Hong WK, Delclos GL, Spitz MR (1997) Association between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis 18:967-973
44. Yunis JJ, Frizzera G, Oken MM, McKenna J, Theologides A, Arnesen M (1987) Multiple recurrent genomic defects in follicular lymphoma. A model for cancer. N Engl J Med 316:79
45. Zamniak P, Nanduri B, Pikula S, Bandorowicz-Pikula J, Singhal SS, Srivastava SK, Awasthi S, Awasthi YC (1994) Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur J Biochem 224:863-899
46. Zhang Q, Siebert R, Yan M, Hinzman B, Cui X, Xue L, et al. (1999) Inactivating mutations and overexpression of BCL-10, a caspase recruitment domain (CARD)-containing gene in MALT lymphoma with t(1;4)(p22;q32). Nat Genet 22:63-68